Monday, September 18, 2017 10:50:42 AM
September 16, 2017
Dear Strategic Tech Investor,
The last time we checked in on Jeff Sessions and his "war on pot," things were not looking good.
In that Aug. 26 "weekender," we noted that Republican operative Roger Stone, White House Chief of Staff John Kelly, and President Donald Trump himself had all lined up on the other side of that "war."
Well, things just got even worse for the beleaguered U.S. Attorney General.
In a pun-filled floor speech Sept. 13, U.S. Sen. Orrin Hatch (R-UT) announced the Marijuana Effective Drug Study Act of 2017 (MEDS Act), which encourages medical marijuana research and helps medical researchers.
"It's high time to address research into medical marijuana," Hatch said. "Our country has experimented with a variety of state solutions without properly delving into the weeds on the effectiveness, safety, dosing, administration, and quality of medical marijuana."
In introducing the legislation, Hatch was joined by Sen. Brian Schatz (D-HI) and cosponsors Sens. Chris Coons (D-DE), Cory Gardner (R-CO), and Thom Tillis (R-NC).
FEATURED POET Wins "Best Optical AI Solution" in 2024 AI Breakthrough Awards Program • Jun 26, 2024 10:09 AM
HealthLynked Promotes Bill Crupi to Chief Operating Officer • HLYK • Jun 26, 2024 8:00 AM
Bantec's Howco Short Term Department of Defense Contract Wins Will Exceed $1,100,000 for the current Quarter • BANT • Jun 25, 2024 10:00 AM
ECGI Holdings Targets $9.7 Billion Equestrian Apparel Market with Allon Brand Launch • ECGI • Jun 25, 2024 8:36 AM
Avant Technologies Addresses Progress on AI Supercomputer-Driven Data Centers • AVAI • Jun 25, 2024 8:00 AM
Green Leaf Innovations, Inc. Expands International Presence with New Partnership in Dubai • GRLF • Jun 24, 2024 8:30 AM